Zobrazeno 1 - 10
of 102
pro vyhledávání: '"Takaaki NAKAI"'
Autor:
Yoshinori Imura, Satoshi Takenaka, Hidetatsu Outani, Takaaki Nakai, Naohiro Yasuda, Sho Nakai, Toru Wakamatsu, Hironari Tamiya, Seiji Okada
Publikováno v:
Current Oncology, Vol 29, Iss 4, Pp 2301-2311 (2022)
Background: Few studies have described the characteristics and prognostic factors of patients with metastatic extrauterine leiomyosarcoma (euLMS). Therefore, we retrospectively investigated the clinicopathological features, clinical outcomes, and pro
Externí odkaz:
https://doaj.org/article/84022c8882074a419af8d27849752875
Autor:
Naohiro Yasuda, Satoshi Takenaka, Sho Nakai, Takaaki Nakai, Shutaro Yamada, Yoshinori Imura, Hidetatsu Outani, Kenichiro Hamada, Hideki Yoshikawa, Norifumi Naka
Publikováno v:
FEBS Open Bio, Vol 10, Iss 5, Pp 767-779 (2020)
Osteosarcoma is the most common malignant bone tumor in adolescence and childhood. Metastatic osteosarcoma has a poor prognosis with an overall 5‐year survival rate of approximately 20%. TAS‐115 is a novel multiple receptor tyrosine kinase inhibi
Externí odkaz:
https://doaj.org/article/5cbf079bfe7f41048f35778ed30cb849
Autor:
Yoshinori Imura, Hidetatsu Outani, Satoshi Takenaka, Naohiro Yasuda, Sho Nakai, Takaaki Nakai, Toru Wakamatsu, Hironari Tamiya, Kenichiro Hamada, Shigeki Kakunaga
Publikováno v:
Sarcoma, Vol 2021 (2021)
Introduction. Few studies have described the characteristics and prognostic factors of patients with malignant peripheral nerve sheath tumour (MPNST). In this study, we retrospectively investigated the clinicopathological features, clinical outcomes,
Externí odkaz:
https://doaj.org/article/824f314714f848e480489e787031bb73
Publikováno v:
Electronics & Communications in Japan. Dec2021, Vol. 104 Issue 4, p1-11. 11p.
Autor:
Shutaro Yamada, Yoshinori Imura, Takaaki Nakai, Sho Nakai, Naohiro Yasuda, Keiko Kaneko, Hidetatsu Outani, Satoshi Takenaka, Kenichiro Hamada, Akira Myoui, Nobuhito Araki, Takafumi Ueda, Kazuyuki Itoh, Hideki Yoshikawa, Norifumi Naka
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-14 (2017)
Abstract Background The prognosis of synovial sarcoma (SS), an aggressive soft tissue sarcoma, remains poor. We previously reported that c-MET or platelet-derived growth factor receptor α (PDGFRα) signalling pathway is related to SS progression bas
Externí odkaz:
https://doaj.org/article/0a9f7289c3704ad280f60fd471aef4c1
Publikováno v:
Denki Kagaku. 90:233-237
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40f4084125b57784012a0f29b9b2583b
https://doi.org/10.5796/denkikagaku.22-fe0020
https://doi.org/10.5796/denkikagaku.22-fe0020
Autor:
Ritsuki Nakajima, Tatsuya Taniguchi, Yuta Sasaki, Yoshinori Nishiki, Zaenal Awaludin, Takaaki Nakai, Akihiro Kato, Shigenori Mitsushima, Yoshiyuki Kuroda
Publikováno v:
ChemSusChem.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b1d5ad94ffe281b6347cda04eed4c7f
https://doi.org/10.1002/cssc.202300384
https://doi.org/10.1002/cssc.202300384
Autor:
Norifumi Naka, Hideki Yoshikawa, Takafumi Ueda, Nobuhito Araki, Akira Myoui, Kenichiro Hamada, Satoshi Takenaka, Hidetatsu Outani, Takaaki Tanaka, Toru Wakamatsu, Naohiro Yasuda, Takaaki Nakai, Yoshinori Imura, Hironari Tamiya, Sho Nakai
Supplementary Figure S2 shows measurement of melanin content and WST-1 cell proliferation assay in Hewga-CCS and MP-CCS-SY cells treated with SCH772984.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b52b025e4e0d154f1baa81f6ea530aa7
https://doi.org/10.1158/1535-7163.22510227.v1
https://doi.org/10.1158/1535-7163.22510227.v1
Autor:
Norifumi Naka, Hideki Yoshikawa, Takafumi Ueda, Nobuhito Araki, Akira Myoui, Kenichiro Hamada, Satoshi Takenaka, Hidetatsu Outani, Takaaki Tanaka, Toru Wakamatsu, Naohiro Yasuda, Takaaki Nakai, Yoshinori Imura, Hironari Tamiya, Sho Nakai
Supplementary Table S1 shows information of antibodies used in this study.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c5db16837731bacc7fa258b212f027a
https://doi.org/10.1158/1535-7163.22510221
https://doi.org/10.1158/1535-7163.22510221
Autor:
Norifumi Naka, Hideki Yoshikawa, Takafumi Ueda, Nobuhito Araki, Akira Myoui, Kenichiro Hamada, Satoshi Takenaka, Hidetatsu Outani, Takaaki Tanaka, Toru Wakamatsu, Naohiro Yasuda, Takaaki Nakai, Yoshinori Imura, Hironari Tamiya, Sho Nakai
Clear cell sarcoma (CCS) is a rare but chemotherapy-resistant and often fatal high-grade soft-tissue sarcoma (STS) characterized by melanocytic differentiation under control of microphthalmia-associated transcription factor (MITF). Eribulin mesilate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59e96492b6534af77cb79745c588bd29
https://doi.org/10.1158/1535-7163.c.6539544.v1
https://doi.org/10.1158/1535-7163.c.6539544.v1